ORBi: Browsing ORBi

MyORBi

Browse ORBi by

ORBi project

The Open Access movement

ORBi is a project of


	References of "Boverie, S." in Showing results 41 to 60 of 103 1 2 3 4 5 6 Pharmacological evaluation of cromakalim analogues: towards the discovery of new inhibitors of insulin secretion from rat pancreatic β-cells Sebille, S.; Becker, B.; Antoine, M. H. et al Poster (2002, March 02) Detailed reference viewed: 3 (0 ULg) Development of 4H-1,2,4-benzothiadiazine 1,1-dioxides as putative tocolytic agents: pharmacological evaluation on different smooth muscle preparations Boverie, S.; Becker, B.; Sebille, S. et al Poster (2002, March 02) Detailed reference viewed: 2 (0 ULg) Action myorelâchante sur la fibre musculaire lisse utérine de nouveaux dérivés de type 4H-1,2,4-benzothiadiazine 1,1-dioxyde diversement substitués en position 3 et 7 Boverie, S.; Dewalque, D.; Sebille, S. et al Conference (2002, January 25) Detailed reference viewed: 2 (0 ULg) 3-R/S-(hydroxyalkylamino)-4H-1,2,4-benzothiadiazine 1,1-dioxides as potential K+ATP channel activators: influence of stereochemistry on biological activity and tissue selectivity Boverie, S.; Becker, B.; Somers, F. et al in Fundamental & Clinical Pharmacology (2002) Detailed reference viewed: 9 (2 ULg) Pharmacological evaluation of cromakalim analogues: towards the discovery of new inhibitors of insulin secretion from rat pancreatic Beta-cells Sebille, S.; becker, B.; Antoine, M. H. et al in Fundamental & Clinical Pharmacology (2002) Detailed reference viewed: 6 (3 ULg) development of 4H-1,2,4-benzothiadiazine 1,1-dioxides as putative tocolytic agents: pharmacological evaluation on diferent smooth muscle preparations Boverie, S.; Becker, B.; Sebille, S. et al in Fundamental & Clinical Pharmacology (2002) Detailed reference viewed: 4 (1 ULg) Pharmacological evaluation of cromakalim analogues: towards the discovery of new inhibitors of insulin secretion from rat pancreatic Beta-cells Sebille, S.; Becker, B.; Antoine, M. H. et al in Fundamental & Clinical Pharmacology (2002) Detailed reference viewed: 5 (1 ULg) Pharmacological evaluation of cromakalim analogues: towards the discovery of new inhibitors of insulin secretion from rat pancreatic -cells Sebille, S.; Becker, B.; Antoine, M. H. et al in Fundamental & Clinical Pharmacology (2002) Detailed reference viewed: 3 (0 ULg) Development of 4H-1,2,4-benzothiadiazine 1,1-dioxides as putative tocolytic agents: pharmacological evaluation on different smooth muscle preparations Becker, B.; Sebille, S.; Antoine, M. H. et al in Fundamental & Clinical Pharmacology (2002) Detailed reference viewed: 6 (0 ULg) Relaxant effect of K+ATP channel openers on the uterine smooth muscle; phrmacological in vitro models De Tullio, Pascal ; Boverie, S.; Dewalque, D. et al in Fundamental & Clinical Pharmacology (2002) Detailed reference viewed: 2 (0 ULg) 2-N-alkylation of 3-alkylamino-substituted 2H-benzo- and 2H-pyridothiadiazine 1,1-dioxides: from K+ATP channel openers to Ca++ channel blockers? De Tullio, Pascal ; Ouedraogo, R.; Becker, B. et al in Fundamental & Clinical Pharmacology (2002) Detailed reference viewed: 18 (4 ULg) 2-Alkyl-3-alkylamino-2H-benzo- and pyridothiadiazine 1,1-dioxides: from K+ATP channel openers to Ca++ channel blockers? Ouedraogo, R.; Becker, B.; Boverie, S. et al in Biological Chemistry (2002), 383 Detailed reference viewed: 7 (0 ULg) Relaxant effect of K+ATP channel openers on the uterine smooth muscle: pharmacological in vitro models De Tullio, Pascal ; Boverie, S.; Dewalque, Daniel et al in Fundamental & Clinical Pharmacology (2002) Detailed reference viewed: 14 (2 ULg) 2-Alkyl-3-alkylamino-2H-benzo- and pyridothiadiazine 1,1-dioxides: Ca++ channel blockers rather than K+ATP channel openers? De Tullio, Pascal ; Becker, B.; Ouedraogo, R. et al Poster (2001, December 08) Detailed reference viewed: 3 (0 ULg) 3-R/S-(hydroxyalkylamino)-4H-1,2,4-benzothiadiazine 1,1-dioxides as potential K+ATP channel activators: influence of stereochemistry on biological activity and tissue selectivity Boverie, S.; Becker, B.; Somers, F. et al Poster (2001, November 17) 2-N-alkylation of 3-alkylamino-substituted 2H-benzo- and 2H-pyridothiadiazine 1,1-dioxides: from K+ATP channel openers to Ca++ channel blockers? De Tullio, Pascal ; Ouedraogo, R.; Becker, B. et al Poster (2001, November 17) Detailed reference viewed: 1 (0 ULg) Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing them Pirotte, Bernard ; De Tullio, Pascal ; Boverie, S. et al Patent (2001) Detailed reference viewed: 3 (1 ULg) Les 3-alkylamino-2-méthyl-2H-benzo- et pyridothiadiazine dioxydes en tant qu’activateurs potentiels des canaux potassiques sensibles à l’ATP De Tullio, Pascal ; Ouedraogo, R.; Boverie, S. et al Poster (2001, June 01) Detailed reference viewed: 1 (0 ULg) Propriétés biologiques des 7-chloro-4H-1,2,4-benzothiadiazine 1,1-dioxydes diversement substitués en position 3: nouveaux analogues du diazoxide Boverie, S.; De Tullio, Pascal ; Becker, B. et al Poster (2001, June 01) Detailed reference viewed: 1 (0 ULg) Synthesis and pharmacological evaluation of 4,6-disubstituted 2,2-dimethylchromans structurally related to the KATP channel opener cromakalim Sebille, S.; Becker, B.; Boverie, S. et al Conference (2001, May) Detailed reference viewed: 2 (1 ULg) 1 2 3 4 5 6

© ULg Library Network | Feedback | ORBi legal notices

xhtml validator

css validator